Fungal spectrum identified by a new slide culture and in vitro drug susceptibility using Etest in fungal keratitis

Current Eye Research

Volumn 30, Issue 12, 2005, Pages 1113-1120

  Qiu, Wen Ya ^a   Yao, Yu Feng ^a   Zhu, Ye Fei ^a   Zhang, Yong Ming ^a   Zhou, Ping ^a   Jin, Yi Qi ^a   Zhang, Bei ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Etest; Fungal identification; Fungal keratitis; Fungal spectrum; Modified slide culture

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; ITRACONAZOLE;

ACREMONIUM; ALTERNARIA; ANTIBIOTIC RESISTANCE; ARTICLE; ASPERGILLUS; BLASTOMYCES; CANDIDA; CHRYSOSPORIUM; CURVULARIA; DIAGNOSTIC TEST; DRUG SENSITIVITY; ETEST; EYE INFECTION; FUNGAL STRAIN; FUNGUS; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; FUSARIUM; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATITIS; KERATOMYCOSIS; MAJOR CLINICAL STUDY; MYCOSIS; PRIORITY JOURNAL; SCEDOSPORIUM; SPECTRUM; SPOROTHRIX; TREATMENT INDICATION; TRICHOPHYTON; YEAST;

ANTIFUNGAL AGENTS; BACTERIOLOGICAL TECHNIQUES; EYE INFECTIONS, FUNGAL; FUNGI; HUMANS; KERATITIS; MICROBIAL SENSITIVITY TESTS; MYCOLOGICAL TYPING TECHNIQUES; MYCOSES;

EID: 29144529842     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1080/02713680500423671     Document Type: Article

References (18)

1. Yao YF, Zhang YM, Zhou P, et al. Therapeutic penetrating keratoplasty in severe fungal keratitis using cryopreserved donor corneas. Br J Ophthalmol. 2003;87:543-547.
2. Davise HL. Medically Important Fungi: A Guide to Identification. 4th ed. Washington, DC: ASM Press; 2002;304-305.
3. Thomas PA. Mycotic keratitis - an underestimated mycosis. J Med Vet Mycol. 1994;32:235-256.
4. Thomas PA. Current perspectives on ophthalmic mycoses. Clin Microbiol Rev. 2003;16:730-797.
5. Rex JH, Pfaller MA. Has antifungal susceptibility testing come of age? Clin Infect Dis. 2002;35:982-989.
6. National Committee for Clinical and Laboratory Standards. 2002. Reference method for broth dilution antif ungal susceptibility testing of yeasts. Approved standard. Second edition. NCCLS document M27-A2. Wayne, PA, USA.
7. National Committee for Clinical and Laboratory Standards. 2002. Reference method for broth dilution antif ungal susceptibility testing of conidium-forming filamentous fungi. Approved standard. NCCLS document M38-A. Wayne, PA, USA.
8. Rex JH, Pfaller MA, Walsh TJ, et al. Antifungal susceptibility testing: practical aspects and current challenges. Clin Microbiol Rev. 2001;14:643-658.
9. Leck AK, Thomas PA, Hagan M, et al. Etiology of suppurative corneal ulcers in Ghana and south India, and epidemiology of fungal keratitis. Br J Ophthalmol. 2002;86:1211-1215.
10. Tanure MA, Cohen EJ, Sudesh S, et al. Spectrum of fungal keratitis at Wills Eye Hospital, Philadelphia, Pennsylvania. Cornea. 2000;19:307-312.
11. Espinel-Ingroff A. Comparison of the E-test with the NCCLS M38-P method for antifungal susceptibility testing of common and emerging pathogenic filamentous fungi. J Clin Microbiol. 2001;39:1360-1367.
12. Pfaller MA, Messer SA, Mills K, Bolmstrom A. In vitro susceptibility testing of filamentous fungi: comparison of Etest and reference microdilution methods for determining itraconazole MICs. J Clin Microbiol. 2000;38:3359-3361.
13. Inoue T, Inoue Y, Asari S, et al. Utility of Etest in choosing appropriate agents to treat fungal keratitis. Cornea. 2001;20:607-609.
14. Pujol I, Guarro J, Gene J, Sala J. In-vitro antifungal susceptibility of clinical and environmental Fusarium spp. strains. J Antimicrob Chemother. 1997;39:163-167.
15. Fridkin SK, Jarvis WR, Epidemiology of nosocomial fungal infection. Clin Microbiol Rev. 1996;9:499-511.
16. Szekely A, Johnson EM, Warnock DW. Comparison of E-test and broth microdilution methods for antifungal drug susceptibility testing of molds. J Clin Microbiol. 1999;37:1480-1483.
17. Pfaller MA, Messer SA, Hollis RJ, et al. Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000. Antimicrob Agents Chemother. 2002;46:1032-1037.
18. Espinel-Ingroff A. Clinical relevance of fungal susceptibility testing and antifungal resistance. Clin Microbiol News. 2000;22:137-140.